157 related articles for article (PubMed ID: 10728946)
1. Efficacy of abciximab readministration in coronary intervention.
Madan M; Kereiakes DJ; Hermiller JB; Rund MM; Tudor G; Anderson L; McDonald MB; Berkowitz SD; Sketch MH; Phillips HR; Tcheng JE
Am J Cardiol; 2000 Feb; 85(4):435-40. PubMed ID: 10728946
[TBL] [Abstract][Full Text] [Related]
2. Abciximab readministration: results of the ReoPro Readministration Registry.
Tcheng JE; Kereiakes DJ; Lincoff AM; George BS; Kleiman NS; Sane DC; Cines DB; Jordan RE; Mascelli MA; Langrall MA; Damaraju L; Schantz A; Effron MB; Braden GA
Circulation; 2001 Aug; 104(8):870-5. PubMed ID: 11514371
[TBL] [Abstract][Full Text] [Related]
3. Abciximab readministration.
Orford JL; Holmes DR
Rev Cardiovasc Med; 2002; 3(2):67-70. PubMed ID: 12447149
[TBL] [Abstract][Full Text] [Related]
4. Readministration of abciximab: interim report of the ReoPro readministration registry.
Tcheng JE; Kereiakes DJ; Braden GA; Jordan RE; Mascelli MA; Langrall MA; Effron MB
Am Heart J; 1999 Jul; 138(1 Pt 2):S33-8. PubMed ID: 10385789
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.
Sane DC; Damaraju LV; Topol EJ; Cabot CF; Mascelli MA; Harrington RA; Simoons ML; Califf RM
J Am Coll Cardiol; 2000 Jul; 36(1):75-83. PubMed ID: 10898416
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
[TBL] [Abstract][Full Text] [Related]
9. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
[TBL] [Abstract][Full Text] [Related]
10. Readministration of abciximab in percutaneous coronary intervention.
Fry ET
J Invasive Cardiol; 1999 Apr; 11(4):251-8. PubMed ID: 10745525
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.
Simoons ML;
Lancet; 2001 Jun; 357(9272):1915-24. PubMed ID: 11425411
[TBL] [Abstract][Full Text] [Related]
12. Bleeding complications of platelet glycoprotein IIb/IIIa inhibitor abciximab (ReoPro ).
Trivedi SM; Shani J; Hollander G
J Invasive Cardiol; 2002 Jul; 14(7):423-5. PubMed ID: 12082199
[TBL] [Abstract][Full Text] [Related]
13. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
Nguyen N; Salib H; Mascarenhas DA
J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
[TBL] [Abstract][Full Text] [Related]
14. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
Lincoff AM; Tcheng JE; Califf RM; Bass T; Popma JJ; Teirstein PS; Kleiman NS; Hattel LJ; Anderson HV; Ferguson JJ; Cabot CF; Anderson KM; Berdan LG; Musco MH; Weisman HF; Topol EJ
Am J Cardiol; 1997 Feb; 79(3):286-91. PubMed ID: 9036746
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.
Berkowitz SD; Sane DC; Sigmon KN; Shavender JH; Harrington RA; Tcheng JE; Topol EJ; Califf RM
J Am Coll Cardiol; 1998 Aug; 32(2):311-9. PubMed ID: 9708455
[TBL] [Abstract][Full Text] [Related]
16. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
17. Emergent operation for percutaneous coronary rupture after abciximab administration.
Roberts CS; Bocanegra NR
Ann Thorac Surg; 2001 Jun; 71(6):2024-6. PubMed ID: 11426792
[TBL] [Abstract][Full Text] [Related]
18. Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
Singh HS; Dangas GD; Guagliumi G; Yu J; Witzenbichler B; Kornowski R; Grines C; Gersh B; Dudek D; Mehran R; Stone GW
Am J Cardiol; 2012 Oct; 110(7):940-7. PubMed ID: 22748356
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.
EPILOG Investigators
N Engl J Med; 1997 Jun; 336(24):1689-96. PubMed ID: 9182212
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]